Report Feature
The future of the antibody production market looks promising with opportunities in pharmaceutical & biotechnology companies and research laboratories. The global antibody production market is expected to grow with a CAGR of 12%-15% from 2020 to 2025. The major drivers for this market are rise in adoption of targeted immunotherapy and increasing R&D activities in the biopharmaceutical & biotechnology industries for the production of antibody therapeutics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global antibody production market report, please download the report brochure.
In this market, monoclonal antibody is the largest type of antibody production, whereas pharmaceutical and biotechnology companies is the largest end use. Growth in various segments of the antibody production market are given below:
The study includes trends and forecast for the global antibody production market by type, process, end use, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Polyclonal Antibody
- Monoclonal Antibody
- Murine
- Chimeric
- Humanized
By Process [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Upstream Processing
- Bioreactors
- Consumables
- Media
- Buffers and Reagents
-
Downstream Processing
- Chromatography Systems
- Chromatography Resins
-
Filtration
- Filtration Systems
- Filtration Consumables and Accessories
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the antibody production model companies profiled in this report include GE Healthcare, Thermo Fisher Scientific, Sartorius, Merck, Pall, Sigma-Aldrich, Eppendorf, Cellab, INTEGRA Biosciences, and FiberCell System.
Lucintel forecasts that monoclonal antibody will remain the largest type segment over the forecast period due to increasing investment in monoclonal antibody research and a large number of antibody-based product launches.
Within this market, pharmaceutical and biotechnology companies will remain the largest end use segment over the forecast period due to the increasing demand of antibodies in various applications of the pharmaceutical and biotechnology production process.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and growth in the pharmaceutical industry.
|
Features of the Global Antibody Production Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global antibody production market by type (polyclonal antibody, monoclonal antibody, murine, chimeric, and humanized), process ((upstream processing (bioreactors, consumables, media, buffers and reagents), downstream processing (chromatography systems, chromatography resins), and filtration (filtration systems and filtration consumables & accessories), end use (pharmaceutical and biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global antibody production market? Q.5 What are the business risks and threats to the global antibody production market? Q.6 What are the emerging trends in this antibody production market and the reasons behind them? Q.7 What are some changing demands of customers in this antibody production market? Q.8 What are the new developments in this antibody production market? Which companies are leading these developments? Q.9 Who are the major players in this antibody production market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this antibody production market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global antibody production market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Type (Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized), Process ((Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories), and End Use (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Antibody Production Market
4.1 Global Antibody Production Market by Region
4.2.1 Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.2.2 Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.2.3 Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.2.4 The United States Antibody Production Market
4.2.5 The Canadian Antibody Production Market
4.2.6 The Mexican Antibody Production Market
4.3.1 Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.3.2 Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.3.3 Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.3.4 The United Kingdom Antibody Production Market
4.3.5 The Spanish Antibody Production Market
4.3.6 The German Antibody Production Market
4.3.7 The French Antibody Production Market
4.4.1 Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.4.2 Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.4.3 Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.4.4 The Chinese Antibody Production Market
4.4.5 The Indian Antibody Production Market
4.4.6 The Japanese Antibody Production Market
4.5.1 Market by Type: Polyclonal Antibody, Monoclonal Antibody, Murine, Chimeric, and Humanized
4.5.2 Market by Process: Upstream processing (Bioreactors, Consumables, Media, Buffers and Reagents), Downstream processing (Chromatography Systems, Chromatography Resins), and Filtration (Filtration Systems and Filtration Consumables & Accessories
4.5.3 Market by End Use: Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others
4.5.4 Brazilian Antibody Production Market
7.1.1 Growth Opportunities for the Global Antibody Production Market by Product
7.1.2 Growth Opportunities for the Global Antibody Production Market by Process
7.1.3 Growth Opportunities for the Global Antibody Production Market by End Use
7.1.4 Growth Opportunities for the Global Antibody Production Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
